TransMedics Group, Inc. (TMDX) Shareholders’ equity 2018–2025
TransMedics Group, Inc. (TMDX) shareholders’ equity at each fiscal year-end, per SEC filings.
$473.1MFY2025 · since FY2018: -$192.2M → $473.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $473.1M | +107.0% |
| FY2024 | $228.6M | +66.6% |
| FY2023 | $137.2M | -26.8% |
| FY2022 | $187.4M | +176.1% |
| FY2021 | $67.9M | -34.7% |
| FY2020 | $103.9M | +90.1% |
| FY2019 | $54.6M | +128.4% |
| FY2018 | -$192.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice